KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Shares Issued (2016 - 2025)

Inovio Pharmaceuticals' Shares Issued history spans 16 years, with the latest figure at $8.3 million for Q3 2025.

  • For Q3 2025, Shares Issued rose 137.19% year-over-year to $8.3 million; the TTM value through Sep 2025 reached $69.1 million, up 1164.93%, while the annual FY2024 figure was $60.8 million, 1013.2% up from the prior year.
  • Shares Issued for Q3 2025 was $8.3 million at Inovio Pharmaceuticals, up from -$1.1 million in the prior quarter.
  • Across five years, Shares Issued topped out at $159.5 million in Q2 2021 and bottomed at -$155.4 million in Q4 2021.
  • The 5-year median for Shares Issued is $2.9 million (2023), against an average of $9.7 million.
  • The largest annual shift saw Shares Issued soared 3503.09% in 2021 before it tumbled 664.44% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$155.4 million in 2021, then surged by 104.29% to $6.7 million in 2022, then decreased by 18.09% to $5.5 million in 2023, then surged by 1013.2% to $60.8 million in 2024, then plummeted by 86.37% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for INO's Shares Issued are $8.3 million (Q3 2025), -$1.1 million (Q2 2025), and $1.1 million (Q1 2025).